Literature DB >> 32702300

Encouraging results from phase 1/2 COVID-19 vaccine trials.

Naor Bar-Zeev1, William J Moss2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32702300     DOI： 10.1016/S0140-6736(20)31611-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  SARS-CoV-2: Unique Challenges of the Virus and Vaccines.

Authors:  Ata Mahmoodpoor; Sarvin Sanaie; Parisa Samadi; Mehdi Yousefi; Nader D Nader
Journal:  Immunol Invest       Date:  2021-06-10       Impact factor: 3.657

Review 2.  Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.

Authors:  Siddhi Tandon; Anchal Aggarwal; Shubhra Jain; Sanjay Shukla; Sarika Chaudhary
Journal:  Protein J       Date:  2020-10-09       Impact factor: 2.371

Review 3.  An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.

Authors:  Louise M Gresham; Barbara Marzario; Jan Dutz; Mark G Kirchhof
Journal:  J Am Acad Dermatol       Date:  2021-01-19       Impact factor: 11.527

Review 4.  Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Garima Sharma; Rudra P Saha; Sang-Soo Lee
Journal:  Immune Netw       Date:  2021-01-19       Impact factor: 6.303

5.  COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.

Authors:  Mazin Barry; Mohamad-Hani Temsah; Abdullah Alhuzaimi; Nurah Alamro; Ayman Al-Eyadhy; Fadi Aljamaan; Basema Saddik; Ali Alhaboob; Fahad Alsohime; Khalid Alhasan; Abdulkarim Alrabiaah; Ali Alaraj; Rabih Halwani; Amr Jamal; Sarah Alsubaie; Fatimah S Al-Shahrani; Ziad A Memish; Jaffar A Al-Tawfiq
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

6.  Adenovirus and RNA-based COVID-19 vaccines' perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey.

Authors:  Mohamad-Hani Temsah; Mazin Barry; Fadi Aljamaan; Abdullah Alhuzaimi; Ayman Al-Eyadhy; Basema Saddik; Abdulkarim Alrabiaah; Fahad Alsohime; Ali Alhaboob; Khalid Alhasan; Ali Alaraj; Rabih Halwani; Nurah Maziad Alamro; Fatimah S Al-Shahrani; Amr Jamal; Sarah Alsubaie; Ziad A Memish; Jaffar A Al-Tawfiq
Journal:  BMJ Open       Date:  2021-06-21       Impact factor: 2.692

7.  Virus database annotations assist in tracing information on patients infected with emerging pathogens.

Authors:  Akiko Nakashima; Mitsue Takeya; Keiji Kuba; Makoto Takano; Noriyuki Nakashima
Journal:  Inform Med Unlocked       Date:  2020-10-08

8.  Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.

Authors:  Maria G Noval; Maria E Kaczmarek; Akiko Koide; Bruno A Rodriguez-Rodriguez; Ping Louie; Takuya Tada; Takamitsu Hattori; Tatyana Panchenko; Larizbeth A Romero; Kai Wen Teng; Andrew Bazley; Maren de Vries; Marie I Samanovic; Jeffrey N Weiser; Ioannis Aifantis; Joan Cangiarella; Mark J Mulligan; Ludovic Desvignes; Meike Dittmann; Nathaniel R Landau; Maria Aguero-Rosenfeld; Shohei Koide; Kenneth A Stapleford
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.996

9.  Amantadine Inhibits SARS-CoV-2 In Vitro.

Authors:  Klaus Fink; Andreas Nitsche; Markus Neumann; Marica Grossegesse; Karl-Heinz Eisele; Wojciech Danysz
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.